FCMV
Foresite Capital Management V Portfolio holdings
AUM
$80.7M
This Quarter Return
+0.09%
1 Year Return
-24.46%
3 Year Return
+66.81%
5 Year Return
–
10 Year Return
–
AUM
$157M
AUM Growth
+$157M
(+47%)
Cap. Flow
+$47.1M
Cap. Flow
% of AUM
30.08%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
2
Increased
1
Reduced
1
Closed
2
Top Buys
| 1 |
ALMS
Alumis Inc. Common Stock
ALMS
|
$74.3M |
| 2 |
Cullinan Oncology
CGEM
|
$11.5M |
| 3 |
Disc Medicine
IRON
|
$2.5M |
Top Sells
| 1 |
Hims & Hers Health
HIMS
|
$31.6M |
| 2 |
KNTE
Kinnate Biopharma Inc. Common Stock
KNTE
|
$9.38M |
| 3 |
ME
23andMe Holding Co. Class A Common Stock
ME
|
$124K |
Sector Composition
| 1 | Healthcare | 77.32% |
| 2 | Consumer Staples | 22.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALMS
1
Alumis Inc. Common Stock
ALMS
$479M
| $74.3M | 47.43% | +5,584,887 | New | +$74.3M |
|
|
2
Hims & Hers Health
HIMS
$9.57B
| $35.5M | 22.68% | 1,759,314 -1,567,469 | -47% | -$31.6M |
|
3
CG Oncology
CGON
$2.04B
| $21.9M | 13.96% | 692,550 | – | – |
|
|
4
Disc Medicine
IRON
$2.07B
| $13.5M | 8.61% | 299,069 +55,556 | +23% | +$2.5M |
|
|
5
Cullinan Oncology
CGEM
$445M
| $11.5M | 7.33% | +657,905 | New | +$11.5M |
|
|
ME
6
DELISTED
23andMe Holding Co. Class A Common Stock
ME
| – | – | -232,200 | Closed | -$124K |
|
|
KNTE
7
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| – | – | -3,525,957 | Closed | -$9.38M |
|